References
- Epstein M. A., Achong B. G. Introduction: discovery and general biology of the virus. The Epstein-Barr virus, M. A. Epstein, B. G. Achong. Springer Verlag, New York 1979; 1–22
- Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Set. U. S. A. 1968; 59: 94–101
- Epstein M. A., Achong B. G., Barr Y. M. Virus particles in cultured lymphoblasls from Burkitt's lymphoma. Lancet 1964; 1: 702–703
- Cheesman S. H., Henle W., Rubin R. H. Epstein Ban-virus infections in renal transplant recipients. Effects of antithymocyte globulin and interferon. Ann. Intern. Med. 1980; 93: 39–42
- Choppuis B. B., Müller H., Stute J., Hey M. M., Hubner K., Muller-Hermelink H. K. Identification of EBV-DNA in lymph nodes from patients with lymphadenopathy and lymphomas associated with AIDS. Virchows Arch. [B] 1990; 56: 199–205
- McClain K. Epstein-Barr virus DNA in lymphocytes of patients with the virus-associated hemophagocytic syndrome. Am. J. Pediatr. Hematol. Oncol 1986; 8: 121–127
- Wilson M. S., Weiss L. M., Gatter K. C., Mason D. Y., Dorfman R. F., Warnke R. A. Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 1990; 66: 530–536
- Fujisaki T., Nagafuchi S., Niho Y., Tsunyoshi M., Oshima K., Kikuchi M. Malignant histiocytosis in a patient with chronic active Epstein-Barr virus infection. Lancet 1992; 2: 1168–1169
- Saito I., Servenius B., Compton T., Fox R. I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J. Exp. Med. 1989; 169: 2191–2198
- Shibata D., Hansmann M., Weiss L. M., Nathwani B. N. Epstein-Barr virus infections and Hodgkin's disease: a study of fixed tissues using the polymerase chain reaction. Hum. Pathol. 1991; 12: 1262–1267
- Boyle M. J., Sewell W. A., Sculley T. B. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood. 1991; 78: 3004–3011
- Chang K. L., Chen Y. Y., Shibata D., Weiss L. M. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissue, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1992; 1: 246–255
- Su I. J., Hsieh H. J., Lee C. Y. Histiocytic medullary reticulosis: a lethal form of primary EBV infection in young children in Taiwan, (letter). Lancet 1989; 1: 389
- Ohshima K., Kikuchi M., Eguchi F., Kobari S., Tasaka H. Virus-associated haemophagocytic syndrome with Epstein-Barr virus infection. Virchows Arch. [A] 1991; 419: 519–522
- Pileri S., Mazza P., Rivano M. T. Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases. Histopathology 1985; 9: 905–920
- Fingeroth J. D., Weiss J. J., Tender T. F., Strominger J. L., Biro P. A., Fearon D. T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 4510–4514
- Bayliss G. J., Wolf H. Epstein-Barr virus-induced cell fusion. Nature 1980; 287: 164–165
- Revoltella R. P., Vigneti E., Fruscalzo A. Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis. J. Gen. Virol. 1989; 70: 1203–1215
- De Waele M., Thielemans C., Van Camp B. J. G. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N. Engl. J. Med. 1981; 304: 460–462
- Rickinson A. B. Cellular immunological responses to the virus infection. The Epstein-Barr virus: recent advances, M. A. Epstein, B. G. Achong. John Wiley, New York 1986; 75
- Murray R. J., Wang D., Young L. S. Epstein-Barr virus specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol. 1988; 62: 3747–3755
- Virelizier J. L., Lenoir G., Griscelli C. Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet 1978; 1: 231–234
- Caligiuri M., Murray C., Buchwald D. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 1987; 139: 3306–3313
- Subira M. L., Castilla A., Civeria M. P. Deficient display of CD3 on lymphocytes of patients with chronic fatigue syndrome. J. Infect. Dis. 1989; 160: 165–166
- Gershwin M. E., Steinberg A. D. Loss of suppressor function as acause of lymphoid malignancy. Lancet 1973; 2: 1174–1176